Canaccord Genuity Downgrades Nevro to Hold, Announces $23 Price Target
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst William Plovanic downgraded Nevro Corp (NYSE:NVRO) from Buy to Hold and set a price target of $23. The downgrade reflects a more cautious stance on the company's stock.
December 21, 2023 | 12:08 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Nevro Corp was downgraded by Canaccord Genuity from Buy to Hold with a price target of $23, indicating a potential stagnation or decrease in stock price.
Downgrades by analysts can lead to a negative perception among investors, potentially causing a short-term decline in the stock price. The setting of a price target can also anchor expectations and may suggest limited upside potential from current levels.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100